Publication:
Assessment of Disease Activity in Large-vessel Vasculitis: Results of an International Delphi Exercise

dc.contributor.authorDİRESKENELİ, RAFİ HANER
dc.contributor.authorsAydin, Sibel Z.; Direskeneli, Haner; Merkel, Peter A.; on behalf of the International Delphi on Disease Activity Assessment in Large-vessel Vasculitis
dc.date.accessioned2022-03-02T05:39:51Z
dc.date.accessioned2026-01-11T15:08:42Z
dc.date.available2022-03-02T05:39:51Z
dc.date.issued2017-12
dc.description.abstractObjective. To arrive at consensus for candidate outcomes for disease activity assessment in large-vessel vasculitis (LVV) in clinical trials. Methods. A Delphi survey including 99 items was circulated among international experts for 3 rounds. Results. Fifty-seven items were accepted for both giant cell arteritis and Takayasu arteritis. Sixty-seven percent of experts voted to have a common approach for both diseases with additional disease-specific items such as weight loss, scalp tenderness/necrosis, morning stiffness, dizziness, visual symptoms, and imaging. Conclusion. This study highlights similarities and differences in experts’ perspectives for assessing clinical activity in LVV and may guide a consensus-driven core set of validated outcomes.
dc.identifier.doi10.3899/jrheum.161269
dc.identifier.issn0315-162X, 1499-2752
dc.identifier.issue12
dc.identifier.pages1928-1932
dc.identifier.urihttps://hdl.handle.net/11424/218554
dc.identifier.volume44
dc.language.isoeng
dc.relation.urihttp://www.jrheum.org/lookup/doi/10.3899/jrheum.161269
dc.titleAssessment of Disease Activity in Large-vessel Vasculitis: Results of an International Delphi Exercise
dc.title.alternativeAssessment of Disease Activity in Large-vessel Vasculitis
dc.typearticle
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
96.73 KB
Format:
Adobe Portable Document Format